CLASS II Device recall · Reported 1 Oct 2014 · FDA Enforcement Report

ABX Pentra Magnesium RTU Reagent recalled by Horiba Instruments

Horiba Instruments is recalling ABX Pentra Magnesium RTU Reagent, distributed nationwide in the US. The recall was initiated on 11 Aug 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lots
Quantity recalled359 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2692-2014
FDA event ID
69105
Recalling firm
Horiba Instruments, Irvine, CA
Classification
Class II
Status
Terminated
Recall initiated
11 Aug 2014
FDA classified
23 Sep 2014
Reported
1 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

11 Aug 2014Recall initiated by company
23 Sep 2014Classified by FDA+43 days
1 Oct 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Horiba Medical is recalling the ABX PENTRA Magnesium RTU Reagent because the on-board stability claims has been updated. Horiba has updated the ABX PENTRA Magnesium RTU package inserts by removing the 7-day on-board stability claim and replacing it with a 1-day on-board stability claim.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

ABX PENTRA Magnesium RTU Reagent, Part No. A11A01646 Product Usage: ABX PENTRA Magnesium RTU reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of magnesium in human serum and plasma based on a photometric test using xylidyl blue. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemnia (abnormally low plasma levels of magnesium) and hypermagnesemnia (abnormally high plasma levels of magnesium).

Where it was distributed

US Nationwide Distribution.

Nationwide

Questions about this recall

Why was it recalled?

Horiba Medical is recalling the ABX PENTRA Magnesium RTU Reagent because the on-board stability claims has been updated. Horiba has updated the ABX PENTRA Magnesium RTU package inserts by removing the 7-day on-board stability claim and replacing it with a 1-day on-board stability claim.

Which lots are affected?

All Lots

Where was it sold?

US Nationwide Distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Horiba Instruments

All 28

Other Test Kits & Diagnostics recalls

All 2,671